Medtronic plc Asset Resilience Ratio

Latest as of April 2026: 7.82%

Medtronic plc asset resilience ratio. Medtronic plc (MDTC34) has an Asset Resilience Ratio of 7.82% as of April 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Medtronic plc defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.

Liquid Assets

R$7.27 Billion
≈ $1.43 Billion USD Cash + Short-term Investments

Total Assets

R$93.03 Billion
≈ $18.25 Billion USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio of Medtronic plc (2019–2026)

Asset resilience ratio of Medtronic plc from 2019 to 2026. This chart shows how Medtronic plc's Asset Resilience Ratio has changed over time. Read Medtronic plc debt and liabilities for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Medtronic plc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see Medtronic plc assets under control.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents R$0.00 0%
Short-term Investments R$7.27 Billion 7.82%
Total Liquid Assets R$7.27 Billion 7.82%

Asset Resilience Insights

  • Limited Liquidity: Medtronic plc maintains only 7.82% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Medtronic plc Industry Peers by Asset Resilience Ratio

Compare Medtronic plc's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Shenzhen New Industries Biomedical
SHE:300832
Medical Devices 9.95%
GN Store Nord
CO:GN
Medical Devices -4.56%
Shanghai Aohua Photoelectricity Endoscope Co. Ltd. A
SHG:688212
Medical Devices 6.09%
Polynovo Ltd
AU:PNV
Medical Devices 0.04%
L&C Bio Co. Ltd
KQ:290650
Medical Devices 2.14%
VIROMED MEDICAL NA O.N.
XETRA:VME
Medical Devices 0.03%
Affluent Medical SAS
PA:AFME
Medical Devices 0.03%
DRGEM Corporation
KQ:263690
Medical Devices 2.12%

Medtronic plc Asset Resilience Ratio by Year (2019–2026)

Medtronic plc asset resilience ratio by year from 2019 to 2026. The table below shows the annual Asset Resilience Ratio data for Medtronic plc.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2026-04-30 7.82% R$7.27 Billion
≈ $1.43 Billion
R$93.03 Billion
≈ $18.25 Billion
-1.96pp
2025-04-30 9.78% R$8.96 Billion
≈ $1.76 Billion
R$91.68 Billion
≈ $17.99 Billion
+0.88pp
2024-04-30 8.90% R$8.01 Billion
≈ $1.57 Billion
R$89.98 Billion
≈ $17.66 Billion
+0.15pp
2023-04-30 8.75% R$7.96 Billion
≈ $1.56 Billion
R$90.95 Billion
≈ $17.85 Billion
-2.87pp
2022-04-30 11.62% R$10.57 Billion
≈ $2.07 Billion
R$90.98 Billion
≈ $17.85 Billion
+0.00pp
2021-04-30 11.62% R$10.82 Billion
≈ $2.12 Billion
R$93.08 Billion
≈ $18.26 Billion
+4.11pp
2020-04-30 7.51% R$6.81 Billion
≈ $1.34 Billion
R$90.69 Billion
≈ $17.79 Billion
+1.43pp
2019-04-30 6.08% R$5.46 Billion
≈ $1.07 Billion
R$89.69 Billion
≈ $17.60 Billion
--
pp = percentage points

About Medtronic plc

SA:MDTC34 Brazil Medical Devices
Market Cap
$104.84 Billion
R$534.32 Billion BRL
Market Cap Rank
#241 Global
#8 in Brazil
Share Price
R$208.39
Change (1 day)
-5.09%
52-Week Range
R$208.39 - R$276.64
All Time High
R$320.76
About

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor sy… Read more